Europe Colorectal Cancer Diagnostics Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others) and Stool-Based Tests (Faecal Immunochemical Test (FIT), Guaiac-Based Faecal Occult Blood Test, and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others)

No. of Pages: 158    |    Report Code: BMIRE00028832    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Colorectal Cancer Diagnostics Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Colorectal Cancer Diagnostics Market – by Modality

1.3.2        Europe Colorectal Cancer Diagnostics Market – by End User

1.3.3        Europe Colorectal Cancer Diagnostics Market – by Country

2.           Europe Colorectal Cancer Diagnostics Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Colorectal Cancer Diagnostics Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert’s Opinion

5.           Europe Colorectal Cancer Diagnostics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Colorectal Cancer

5.1.2        Launches of New Products

5.2         Key Restraints

5.2.1        Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)

5.3         Future Trends

5.3.1        Artificial Intelligence in Colonoscopy

5.4         Impact Analysis

6.           Colorectal Cancer Diagnostics Market – Europe Analysis

6.1         Europe Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis

7.           Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality

7.1         Overview

7.2         Europe Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)

7.3         Stool Based Tests

7.3.1        Overview

7.3.2        Stool Based Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Faecal Immunochemical Test (FIT)

7.3.3.1          Overview

7.3.3.2          Faecal Immunochemical Test (FIT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Guaiac-based Faecal Occult Blood Test (gFOBT)

7.3.4.1          Overview

7.3.4.2          Guaiac-based Faecal Occult Blood Test (gFOBT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Stool DNA Test

7.3.5.1          Overview

7.3.5.2          Stool DNA Test: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Imaging Tests

7.4.1        Overview

7.4.2        Imaging Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Colonoscopy

7.4.3.1          Overview

7.4.3.2          Colonoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        CT Colonography

7.4.4.1          Overview

7.4.4.2          CT Colonography: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Flexible Sigmoidoscopy

7.4.5.1          Overview

7.4.5.2          Flexible Sigmoidoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6        Capsule Endoscopy

7.4.6.1          Overview

7.4.6.2          Capsule Endoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

7.4.7        Others

7.4.7.1          Overview

7.4.7.2          Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User

8.1         Overview

8.2         Europe Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Diagnostic Laboratories

8.4.1        Overview

8.4.2        Diagnostic Laboratories: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Cancer Research Institutes

8.5.1        Overview

8.5.2        Cancer Research Institutes: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Country Analysis

9.1         Overview

9.1.1        Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

9.1.1.1          Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1          Overview

9.1.1.1.2          Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.3          Germany: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.1.3.1        Germany: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.1.3.2        Germany: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.1.4          Germany: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.2          UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1          Overview

9.1.1.2.2          UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.3          UK: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.2.3.1        UK: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.2.3.2        UK: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.2.4          UK: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.3          France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1          Overview

9.1.1.3.2          France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.3          France: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.3.3.1        France: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.3.3.2        France: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.3.4          France: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.4          Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.1          Overview

9.1.1.4.2          Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.4.3          Italy: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.4.3.1        Italy: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.4.3.2        Italy: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.4.4          Italy: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.5          Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.1          Overview

9.1.1.5.2          Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.5.3          Spain: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.5.3.1        Spain: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.5.3.2        Spain: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.5.4          Spain: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

9.1.1.6          Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.1          Overview

9.1.1.6.2          Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.6.3          Rest of Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)

9.1.1.6.3.1        Rest of Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)

9.1.1.6.3.2        Rest of Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)

9.1.1.6.4          Rest of Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)

10.        Europe Colorectal Cancer Diagnostics Market–Industry Landscape

10.1      Overview

10.2      Inorganic Growth Strategies

10.2.1     Overview

10.3      Organic Growth Strategies

10.3.1     Overview

11.        Company Profiles

11.1      Medtronic Plc

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Illumina Inc

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Epigenomics AG

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      F. Hoffmann-La Roche Ltd

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      Quest Diagnostics Inc

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Novigenix SA

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Siemens Healthineers AG

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Bruker Corp

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Eiken Chemical Co., Ltd.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

12.        Appendix

12.1      About The Insight Partners

12.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Europe Colorectal Cancer Diagnostics Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             Screening approach for colorectal cancer followed in Germany is mentioned in the given Table:

Table 3.             Germany Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Germany Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Germany Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Germany Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             UK Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 8.             UK Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 9.             UK Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 10.          UK Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 11.          France Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 12.          France Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 13.          France Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Italy Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Italy Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Italy Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Italy Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Spain Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Spain Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Spain Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Spain Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Rest of Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Rest of Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Rest of Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Rest of Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Recent Inorganic Growth Strategies in the Europe colorectal cancer diagnostics market

Table 28.          Recent Organic Growth Strategies in the Europe colorectal cancer diagnostics market

Table 29.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Colorectal Cancer Diagnostics Market Segmentation

Figure 2.           Europe Colorectal Cancer Diagnostics Market, by Country

Figure 3.           Europe Colorectal Cancer Diagnostics Market Overview

Figure 4.           Imaging Tests Segment Held Largest Share of Modality Segment in Europe Colorectal Cancer Diagnostics Market

Figure 5.           France Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Europe Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints

Figure 9.           Europe Colorectal Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Europe Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)

Figure 11.        Stool Based Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Faecal Immunochemical Test (FIT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Guaiac-based Faecal Occult Blood Test (gFOBT): Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028  (US$ Million)

Figure 14.        Stool DNA Test: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Imaging Tests: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Colonoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        CT Colonography: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Flexible Sigmoidoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Capsule Endoscopy: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)

Figure 22.        Hospitals: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Laboratories: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Cancer Research Institutes: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Others: Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 27.        Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)

Figure 28.        Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

The List of Companies - Europe Colorectal Cancer Diagnostics Market

  1. Bruker Corp                                            
  2. Eiken Chemical Co., Ltd.                       
  3. Epigenomics AG                                       
  4. F. Hoffmann-La Roche Ltd                     
  5. Illumina Inc         
  6. Medtronic Plc    
  7. Novigenix SA                                           
  8. Quest Diagnostics Inc                          
  9. Siemens Healthineers AG